
-
AN2 Therapeutics NASDAQ:ANTX
Location: | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-47.5M
Cash
83.62M
Avg Qtr Burn
-12.31M
Short % of Float
0.47%
Insider Ownership
22.89%
Institutional Own.
45.73%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Epetraborole Details Melioidosis | Phase 2 Initiation | |
AN2-502998 Details Chagas disease | Phase 1 Initiation | |
Epetraborole Details Mycobacterium avium complex lung disease | Failed Discontinued |